thalidomide has been researched along with Anemia, Iron-Deficiency in 2 studies
Thalidomide: A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.
thalidomide : A racemate comprising equimolar amounts of R- and S-thalidomide.
2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione : A dicarboximide that is isoindole-1,3(2H)-dione in which the hydrogen attached to the nitrogen is substituted by a 2,6-dioxopiperidin-3-yl group.
Anemia, Iron-Deficiency: Anemia characterized by decreased or absent iron stores, low serum iron concentration, low transferrin saturation, and low hemoglobin concentration or hematocrit value. The erythrocytes are hypochromic and microcytic and the iron binding capacity is increased.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Treatment with thalidomide seems an effective therapy for patients with frequently recurring gastrointestinal blood loss due to angiodysplasias who no longer tolerate conventional and invasive procedures due to their physical condition." | 5.33 | [Thalidomide for the treatment of recurrent gastrointestinal blood loss due to intestinal angiodysplasias]. ( de Koning, DB; Drenth, JP; Friederich, P; Nagengast, FM, 2006) |
| "Treatment with thalidomide seems an effective therapy for patients with frequently recurring gastrointestinal blood loss due to angiodysplasias who no longer tolerate conventional and invasive procedures due to their physical condition." | 1.33 | [Thalidomide for the treatment of recurrent gastrointestinal blood loss due to intestinal angiodysplasias]. ( de Koning, DB; Drenth, JP; Friederich, P; Nagengast, FM, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fraiman, G | 1 |
| Ganti, AK | 1 |
| Potti, A | 1 |
| Mehdi, S | 1 |
| de Koning, DB | 1 |
| Drenth, JP | 1 |
| Friederich, P | 1 |
| Nagengast, FM | 1 |
2 other studies available for thalidomide and Anemia, Iron-Deficiency
| Article | Year |
|---|---|
Angiosarcoma of the small intestine: a possible role for thalidomide?
Topics: Aged; Aged, 80 and over; Anemia, Iron-Deficiency; Angiogenesis Inhibitors; Hemangiosarcoma; Humans; | 2003 |
[Thalidomide for the treatment of recurrent gastrointestinal blood loss due to intestinal angiodysplasias].
Topics: Aged, 80 and over; Anemia, Iron-Deficiency; Angiodysplasia; Angiogenesis Inhibitors; Blood Transfusi | 2006 |